We performed a systematic review to define the long-term health problems and optimal treatment strategy for patients with neuroblastoma with intraspinal extension. Of 685 identified studies, 28 were included in this review. The burden of long-term health problems is high; a median of 50% of patients suffered from neurological motor deficit, 34% from sphincter dysfunction, and 30% from spinal deformity. The currently available literature remains suboptimal as a guide for treatment of NBL with intraspinal extension. More well-designed, prospective studies are needed to determine the optimal treatment strategy.
INTRODUCTION
Neuroblastoma (NBL), a malignancy of the sympathetic nervous system, may extend into the intervertebral foramina, especially when arising from the sympathetic side chain, and consequently induce spinal cord and/or nerve root compression with symptoms of neurological motor and sensory deficit, sphincter dysfunction, and pain. 1 These symptoms are a medical emergency and require prompt initiation of treatment to prevent these symptoms to become permanent, irreversible neurological changes. 2 An accurate and timely diagnosis, however, is challenging because of difficulties in expressing and/or assessing these symptoms in young children. Relief of symptoms can be obtained by neurosurgical decompression, 3, 4 radiotherapy (RT), 5, 6 and chemotherapy, [7] [8] [9] but all these therapeutic modalities are associated with short-and long-term morbidities. 10, 11 Neurosurgical intervention leads to immediate spinal decompression and is considered the most appropriate treatment modality Abbreviations: EFS, event-free survival; NBL, neuroblastoma; OS, overall survival; RT, radiotherapy for patients with differentiated tumors, which are unresponsive to chemotherapy and for patients who have neurological deterioration despite receiving chemotherapy. Orthopedic problems, particularly progressive spinal deformity, typically ensue, although it is reported that modern, less invasive neurosurgical techniques may lead to less treatment-associated long-term health problems. 12, 13 Nonetheless, spinal cord ischemia leading to complete paraplegia is described as surgical complication. 14 RT is mainly associated with problems of growth and development [15] [16] [17] [18] ; furthermore, postirradiation thyroid problems are reported when the upper spine is involved. 19, 20 Both RT and laminectomy were found to be the major risk factors for the development of scoliosis in children treated for NBL. 21 Since Hayes et al. demonstrated in 1984 that chemotherapy is an excellent alternative in control of NBL with intraspinal extension, the mainstay of treatment shifted from neurosurgery in combination with RT to initial chemotherapy with avoidance of neurosurgery and RT. 7 Chemotherapy does not lead to immediate relief of spinal cord compression; however, the therapeutic time window seems to extend beyond the first hours of paralysis. 9 Second malignant neoplasms, especially after highdose regimens, [22] [23] [24] ototoxicity as a consequence of platinum-based antineoplastic drug administration, [25] [26] [27] and anthracycline-induced cardiotoxicity [28] [29] [30] are some of the well-documented long-term health problems encountered after chemotherapy.
The optimal treatment strategy for patients affected by NBL with intraspinal extension is still unclear; more specifically, the questions which children can be treated by chemotherapy alone and when neurosurgery should be employed to prevent life-long paraplegia remain unanswered. Meanwhile, survivors of this type of childhood cancer continue to suffer from long-term health problems, it is unclear whether these are caused by disease and/or treatment. To reduce these complications and to establish adequate treatment and followup protocols, more insight into the treatment, outcome, and especially the prevalence of long-term health problems is essential. In this systematic review, we evaluated and summarized all available evidence with regard to treatment and long-term outcome of patients suffering from NBL with intraspinal extension.
METHODS

Search strategy for identification of studies
The objective of the literature search was to identify all studies reporting on treatment and outcome of patients with NBL with intraspinal extension, with particular attention for long-term health problems.
At the start of the selection process, MEDLINE/PubMed (from 1945 to 2016) and EMBASE/Ovid (from 1947 to 2016) were searched for potentially relevant articles. The search strategy used can be found in Supplementary Table S1 .
After performing the search strategy, two reviewers (KK and AJB) independently selected studies that met predefined inclusion criteria:
(i) original reports; (ii) all study designs other than case report/case series; (iii) study population of at least 10 childhood patients with NBL with intraspinal extension; (iv) survival, neurological outcome, and/or prevalence of long-term health problems as outcome. Studies reporting on NBL patients with spinal involvement as a consequence of osteomedullary metastases or relapsed disease were not considered for this review. To be included in this systematic review, each article had to meet all four criteria. Interobserver agreement was calculated. Discrepancies between reviewers were resolved by consensus or consultation of a third reviewer (HvdP). The reference lists of all relevant articles were screened for additional references not registered in MEDLINE or EMBASE. The study selection process was aided by Early Review Organizing Software (developer IECS, Argentina).
Data collection
Two reviewers (KK and TB) independently performed data extraction using a standardized data abstraction form including information about study characteristics, study population, symptoms at diagnosis, characteristics of interventions and response to treatment, duration and completion of follow-up, long-term health problems, and risk/prognostic factors for morbidity.
Quality assessment of the included studies
The assessment of risk of bias was based on earlier described criteria for observational studies according to Evidence-Based Medicine Criteria. 31, 32 Each study was graded on the basis of these dichotomous criteria, concerning the study group, the follow-up, the outcome assessment, methods used for risk estimation, and adjustment for confounding factors. The risk of bias assessment criteria are described in detail in Supplementary Table S2 . Bernardi et al., 1 Angelini et al., 10 and De Bernardi et al. 51 A flow chart of the search and selection process can be found in Supplementary   Fig. S3 ).
RESULTS
Selection of articles
Characteristics of NBL with intraspinal extension
In Table 1 , characteristics of patients with intraspinal extension and the corresponding whole cohort are shown. Three studies reported lower age at diagnosis in patients with intraspinal extension compared to other NBL patients, 8, 46, 50 the difference being significant in only one study. 50 More thoracic tumors were observed in three studies. 8, 46, 50 Two studies found a lower rate of disseminated disease compared to NBL patients without spinal cord compression. 46, 50 Six studies found an overall survival (OS) benefit for NBL patients with intraspinal extension compared to patients without spinal involvement, 8, 37, 46, [49] [50] [51] the difference being significant in only two studies. 46, 50 An improved event-free survival (EFS) was reported in four studies, 8, 44, 50, 51 the difference being significant in only one study. 44 Perez et al. found a significant adverse effect on EFS, but not on OS for stage II NBL patients with intraspinal extension. 45 Sixteen studies reported both the number of symptomatic and asymptomatic patients with intraspinal extension in the total NBL cohort (see Supplementary Table S4 The median prevalence of symptomatic spinal cord compression within the whole NBL cohort was 5.2% (range 4.6-21.3%). to 100%. 1, 10, 34, 35, 41, 46, 48, 50, 51 The severity of the motor deficit at diagnosis was reported in 15 studies. 1, 8, 10, 11, 34, 37, 41, 42, [46] [47] [48] [49] [50] [51] 53 The symptom to diagnosis interval, reported as a mean or median, showed considerable variation, ranging from 3 days to 2 months (median 25.5 days). 1, 8, 10, 11, [33] [34] [35] 37, [46] [47] [48] [49] [50] [51] 53 Nineteen studies reported on the prevalence of neurological motor deficit at the end of follow-up, which ranged from 17 to 69% (median 50%). 1, 8, 10, 11, [33] [34] [35] [36] [37] 40, 41, [46] [47] [48] [50] [51] [52] [53] Fourteen studies described the severity of the motor deficit at this time point. 1, 8, 10, 11, [33] [34] [35] 41, [46] [47] [48] 50, 51, 53 Because of lack of uniformity in classification criteria, a comparison between the studies was not possible.
Neurological motor deficit
Of the 19 studies that reported both the prevalence at diagnosis and at the end of follow-up, 17 studies showed a decreased prevalence, and only two studies showed an increased prevalence of the motor deficit after time (Supplementary Fig. S5A ). 37, 40 Variables affecting neurological motor deficit reported in the various studies are listed in Table 2 . Seven studies found a directly proportional association between neurological deficit at diagnosis and neurological outcome. 10, 11, [46] [47] [48] [49] [50] Four studies found no statistically significant association between treatment modality and neurological outcome. 47, [50] [51] [52] However, multivariate analysis indicated a significant association between motor sequela and neurosurgery. 10 The evidence on the role of the symptom-diagnosis interval in the occurrence of late motor deficit is ambiguous; three studies report a significant better outcome with shorter symptom-diagnosis interval, 49,51,52 while two studies found no association between the two parameters. 10,50 Figure 1 and Supplementary Fig. S5B show the prevalence of sphincter dysfunction at diagnosis and at the end of follow-up. Bladder dysfunction was present at diagnosis in 37% (6-53%) and at end of followup in 25% (9-50%) of patients in, respectively, 11 10, 11, 33, 34, 37, 47, [49] [50] [51] [52] [53] and nine studies. 10, 11, 35, 37, 47, [49] [50] [51] 53 Bowel dysfunction was present at diagnosis in 30% (4-53%) and at end of follow-up in 16% Fig. S5B ).
Sphincter dysfunction
Variables affecting sphincter dysfunction reported in the various studies are listed in Table 3 . Angelini et al. reported significant less sphincter dysfunction in the group treated with chemotherapy. 10 De
Bernardi et al. also found an advantageous outcome for the group treated with chemotherapy in comparison with neurosurgery; however, this difference did not reach statistical significance. 51 The symptomatology at diagnosis (motor deficit and/or sphincter dysfunction) has strong predictive value for sphincter problems experienced at the end of follow-up. 10 
Treatment
A wide variation in treatment of NBL with intraspinal extension was found. Twenty-two studies provided data on the number of children treated with neurosurgery, RT, and/or chemotherapy. 1, 8, 10, 11, [33] [34] [35] [36] [37] 41, 42, [46] [47] [48] [49] [50] [51] [52] [53] The percentage of children treated with neurosurgery ranged from 0 to 95% (median 48.5%). In the nine studies published before 2000, the median was 80%. 8, 11, [33] [34] [35] [36] [37] 41, 42 In the 13 studies published since 2000, the median was 33% 1,10,46-53 (see also Supplementary Table S6 ). The percentage of children treated with RT ranged from 0 to 100% (median 14.5% (overall) ; 81% (pre-2000) ; 8% (post-2000) ), and with chemotherapy from 19 to 100% (median 88% (overall) ; 65% (pre-2000) ; 91% (post-2000) ).
The effect of the administration of glucocorticoids on the shortand long-term neurological outcome was analyzed in only one study. 50 In the study of Simon et al., it was associated with improved early symptom relief, while glucocorticoids did not prevent late residual impairment (see also Table 2 ). 
Follow-up and survival
Spinal deformity and other long-term health problems
Ten studies mentioned the prevalence of long-term health problems in survivors of NBL with intraspinal extension, which varied between 41
and 95% (median 59%). 1, 8, 10, 11, [35] [36] [37] 46, 51, 53 Nineteen studies reported on the prevalence of spinal deformity at the end of follow-up, which ranged from 0 to 80% (median 30%). 1, 8, 10, 11, [33] [34] [35] [36] [37] 41, 42, [46] [47] [48] [49] [50] [51] 53 Less spinal deformity is reported in the studies published after the year 2000 (see Supplementary Table S6 ).
Variables affecting spinal deformity and other long-term health problems reported in the various studies are listed in Table 3 . Neurosurgery and RT as risk factor for the development of spinal deformity are identified in multivariate analysis in the study of Angelini et al. 10 The association between neurosurgery and/or RT and the development of spinal deformity was found in more studies. 11, 42, 46, 47, 49 However, in the study of De Bernardi et al., the difference in prevalence of spinal deformity between the group treated with neurosurgery and chemotherapy was not statistically significant. 51 The association between the primary tumor location and the prevalence of spinal deformity is disputed. Two studies found more spinal deformity with thoracic located tumors, 33, 47 while two other studies did not found such an association. 10,41
Asymptomatic patients with intraspinal extension
In 19 studies, a total of 275 patients with intraspinal extension but without neurological symptoms at diagnosis are described. 1, 8, 11, 33, [36] [37] [38] [39] [40] [42] [43] [44] [45] 47, 49, 52, 53 In these patients, the intraspinal tumor extension is a radiological or seldom a perioperative finding.
For the majority (n = 152) of these patients, it is unclear which treatment was applied, either because no details on treatment are provided or because reports are on symptomatic patients only. 1, 33, 39, 40, [43] [44] [45] 49, 52 In eight studies, a subset (22/98 = 22%) of asymptomatic patients received neurosurgery despite the absence of neurological symptoms. 
TA B L E 2 Variables affecting neurological motor deficit
Independent variable Effect on neurological motor deficit P value
Neurologic deficit at diagnosis Favors worse outcome
Hoover et al. 11 Severe deficit: 27% recovery versus Mild/moderate deficit: 75% recovery -De Bernardi et al. 46 Grade 1: 74% recovery/improvement; Grade 2: 64%; Grade 3: 0% -Katzenstein et al. 47 Direct relation severity symptoms at dx and neuro outcome 0.044
More complete neuro recovery with mild symptoms at dx 0.017
Yiin et al. 48 Mild symptoms: 100% recovery/improvement; moderate 71%; severe 33% -Aydin et al. 49 Lower recovery rate with severe deficit at dx 0.002
Angelini et al. 10 Severe deficit at dx: more motor sequela (OR 12.8, CI 3.5-46.6) <0.001 MV Simon et al. 50 More residual motor impairment with severe deficit at dx 0.03
Symptom diagnosis interval Favors worse outcome
Traggis et al. 34 S-D interval 2 w (full neuro recovery), 4 w (partial recovery), 14 w (no recovery) -Holgersen et al. 36 S-D interval ≤4 w best prognostic factor for reversal neuro deficit -Katzenstein et al. 47 Severe symptoms at dx: inverse relation S-D interval and neuro recovery Complete recovery 78.6% (SDI ≤4 w symptoms) versus 25% (SDI >4 w) 0.008
No effect
De Bernardi et al. 46 No correlation S-D interval and neurologic response to treatment -Angelini et al. 10 No association S-D interval and motor sequela 0.89
Simon et al. 50 No association S-D interval and late effects 0.94
Neurosurgery
Favors worse outcome
Angelini et al.
10
Neurosurgery: more motor sequela (OR 2.5, CI 1.1-5.7) 0.006 MV
No effect
Katzenstein et al. 47 No association treatment modality and neurologic outcome MV Simon et al. 50 Early response symptoms 64% (CT) versus 69% (neurosurgery) 0 No association neurologic outcome and therapy (CT ± steroids versus neurosurgery) 0.37
Glucocorticoids
Favors improved outcome
Simon et al. 50 Early symptom relief/deterioration 70%/0% (steroids) versus 62%/8% (no steroids)
0.03
No effect
Simon et al. 50 Late residual impairment 67.5% (steroids) versus 74.6% (no steroids) 0.50
Age at diagnosis Favors worse outcome
Punt et al. 35 Symptomatic SCC from birth associated with worse neurological outcomeAngelini et al.
10
<2 y age at dx: more motor sequela (OR 0.37, CI 0.13-1.06) 0.033 MV
No effect
Katzenstein et al. 47 No association age at diagnosis and neurological outcome -(Continues)
TA B L E 2 (Continued)
Independent variable Effect on neurological motor deficit P value
Aydin et al. 49 No association age at diagnosis and neurological improvement 0.3
Fawzy et al. 52 No association age at diagnosis and neurological improvement 0.12
Primary tumor site No effect
Katzenstein et al. 47 No association primary tumor site and neurological outcome -Angelini et al. 10 No association primary tumor site and neurological sequelae 0.55
Fawzy et al. 52 No association primary tumor site and neurological outcome -
Stage/NMA No effect
Katzenstein et al. 47 No association stage/NMA and neurological outcome -Fawzy et al. 52 No association stage and neurological outcome 0.14
Percentage spinal canal invasion No effect
De Bernardi et al. 51 No 
Quality assessment of the included studies
Data on the internal and external validity of the 28 cohort studies are shown in Table 4 . All studies were found to have methodological limitations. Eight of the 28 studies (28.6%) showed serious limitations defined as a validity score ≤4. 11, [35] [36] [37] [39] [40] [41] 43 In four of the 28 studies, the study group was not well defined, since it was unclear whether the study population consisted of NBL with intraspinal extension, metastatic spinal cord compression, or a combination of both. 37, 39, 41, 43 In five studies, there is an increased risk of an unrepresentative study group. Four have a risk for selection bias because the number of patients in the whole original cohort was not mentioned. 11, 35, 36, 47 In one study, exclusion of patients due to missing data posed a risk of an unrepresentative study group. 51 Twentyseven (96.4%) studies reported the length of follow-up and therefore had a well-defined follow-up. 1, 8, 10, 11, [33] [34] [35] [36] [37] [38] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] All studies had an adequate follow-up (100%), meaning that the outcome was assessed for more than 90% of the study group of interest. In three of the 28 studies, the outcome definitions were considered not objective and/or imprecise. These studies lacked a well-defined classification scheme for the evaluation of impaired motor function. 36, 40, 43 None of the studies reported that the outcome was assessed by an investigator who was blinded for the treatment status of the patients. Eight studies (28.6%) assessed the influence of prognostic/risk factors on survival, neurological outcome, and/or long-term health problems. 10 
DISCUSSION
In this review, all available evidence on treatment and outcome of patients suffering from NBL with intraspinal extension was critically evaluated from 28 studies that met the inclusion criteria. All studies had methodological limitations. We found that a median of 14.6% of NBL is complicated by an intraspinal extension, of which 63.2% gives rise to neurological symptoms. 1, 8, 33, [37] [38] [39] [40] [42] [43] [44] [45] 49, 52, 53 These patients seem to differ from NBL patients without intraspinal extension with younger age at diagnosis, less abdominally located primary tumors, more low stage disease, less MYCN amplification, and more favorable histology. 8, 46, 50 Differences in these patient characteristics may explain the superior OS for patients with intraspinal extension found in six studies 8, 37, 46, [49] [50] [51] (while significant in only two studies 46, 50 ) .
A recent report by Vo et al. indicated that thoracic located primary tumors showed less MYCN amplification, less disseminated disease, and a superior OS and EFS. 54 The biological origin of these differences remains unknown and is hopefully elucidated in future research to allow for a risk-based treatment approach. 
<0.001 MV
Age at diagnosis No effect
Angelini et al. 10 No association age at dx and sphincter dysfunction 0.46
Primary tumor site No effect
Angelini et al. 10 No association primary tumor site and sphincter dysfunction 0.27
Symptom-diagnosis interval No effect
Angelini et al. 10 No association S-D interval and sphincter dysfunction 0.7 Thoracic tumors: scoliosis 13% versus nonthoracic: 4% -
Independent variable
No effect
Conrad et al. 41 No association extent or level of laminectomy and spinal deformity -Angelini et al. 10 No association primary tumor site and spinal deformity 0.82
Age at diagnosis Favors worse outcome
Conrad et al. 41 Association younger age at treatment and spinal deformity
MV
No effect
Angelini et al. 10 No association age at diagnosis and spinal deformity 0.68 (Continues) With longer follow-up, more patients will be at risk for late treatmentor disease-related health problems. Spinal deformity tends to aggravate during puberty and is a classic example of a health problem that can significantly worsen with prolonged follow-up. [55] [56] [57] [58] Cautious interpretation of results is warranted when it is not clear whether risks of long-term health problems will continue to increase with time.
The severity of the symptoms at diagnosis and the treatment modalities applied were most associated with the presence of long-term health problems. It seems uncontroverted that the severity of the neurological motor deficit at diagnosis has the most predictive power for the neurological outcome. 10, 11, [46] [47] [48] [49] [50] The motor deficit at diagnosis is also significantly associated with spinal deformity and sphincter dysfunction at the end of follow-up, while sphincter dysfunction at diagnosis was correlated with long-term sphincter problems. 10 Initiation of treatment before symptoms have deteriorated to complete loss of neurological function seems, therefore, of the utmost importance.
The correlation between the presence and severity of health problems and treatment modality remains very difficult, as more severely affected patients tend to receive the most aggressive treatment.
Besides, treatment-related spinal deformity is accompanied by tumorinduced destruction of spinal anatomy making elucidation of each relative role hard, if not impossible. Three of the more recent studies found no significant difference between chemotherapy and neurosurgery in the ability to relieve neurological motor deficit. [50] [51] [52] Due to small sample sizes and consequent limited statistical power, differences found were often not significant. Angelini et al. did find significantly more motor sequela after neurosurgery and less sphincter dysfunction after chemotherapy. 10 The presence of spinal deformity is strongly associated with neurosurgical treatment and RT. 10, 42, 46, 47 However, it should be mentioned that the historical nature of this review leaves the advancements made in pediatric neurosurgery underexposed. 12, 13 Only two studies conducted a multivariate analysis. 10, 47 Results from univariate analyses that do not take possible confounding factors into account may lead to an overestimation of the true prognostic influence of a single variable. This systematic review has shown that the burden of long-term health problems in survivors of NBL with intraspinal extension is high. As results from this and other studies will become available, clinicians will be able to make better-informed decisions on treatment for future patients. Until that time, we can only advise to follow international protocol recommendations to limit neurosurgery to patients with rapid neurological deterioration only; to maintain a high index of suspicion for neurological symptoms as presenting symptoms of NBL with intraspinal extension; and to develop targeted follow-up programs for survivors who frequently suffer from long-term health problems.
TA B L E 4 Quality assessment of included studies
